{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:32:34Z","timestamp":1778049154368,"version":"3.51.4"},"reference-count":22,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"crossref","award":["PRJ-6784, PRJ-6785, PRJ-6786, PRJ-6787, PRJ-6788"],"award-info":[{"award-number":["PRJ-6784, PRJ-6785, PRJ-6786, PRJ-6787, PRJ-6788"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"crossref","award":["PRJ-6789"],"award-info":[{"award-number":["PRJ-6789"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2025,7,2]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lassa fever (LF), a viral haemorrhagic disease, poses a significant public health challenge in West Africa. Lassa virus infection frequently causes mild malaria-like symptoms, potentially leading to misdiagnosis and an underestimated burden. Severe LF can lead to multi-organ failure, and survivors may experience sensorineural hearing loss (SNHL). Building on the contributions of the Enable Lassa Research Programme (ENABLE 1.0), which ran in West Africa from 2020 to 2024, ENABLE 1.5 aims to further address gaps in understanding LF disease burden to inform future late-stage vaccine trials. The study will assess the incidence of symptomatic reverse transcription (RT)-PCR-confirmed LF disease, including malaria coinfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The ENABLE 1.5 prospective cohort study will be conducted across five study sites: one in Liberia, three in Nigeria and one in Sierra Leone. Stratified cluster sampling will identify eligible individuals at the household level from communities either involved in ENABLE 1.0 or identified through recent LF surveillance as hotspots. A total of 5000 participants will be recruited, 1000 per study site (minimum) and equally stratified in the following ages: 0\u20135, 6\u201310, 11\u201317, 18\u201350 and &gt;50 years. All participants will be followed up for 12 months. Baseline data collection will gather key variables and blood specimens from all participants, with baseline SNHL prevalence assessed at three study sites. Active follow-up of all participants will involve symptom assessments every 2\u2009weeks and blood draws every 3\u2009months for serological testing (IgG). Suspected LF cases will undergo thorough evaluations, including malaria rapid diagnostic testing, clinical assessments and laboratory testing, including RT-PCR and malaria blood smear microscopy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2024-001960","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T08:40:10Z","timestamp":1753951210000},"page":"e001960","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme (\u2018ENABLE 1.5\u2019) \u2013 study protocol"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-1601","authenticated-orcid":false,"given":"Henshaw","family":"Mandi","sequence":"first","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Asogun","sequence":"additional","affiliation":[{"name":"Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufemi","family":"Ayodeji","sequence":"additional","affiliation":[{"name":"Federal Medical Centre Owo, Owo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict N","family":"Azuogu","sequence":"additional","affiliation":[{"name":"Alex Ekwueme Federal University Teaching Hospital Abakaliki, Abakaliki, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Camacho","sequence":"additional","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-098X","authenticated-orcid":false,"given":"William","family":"Fischer","sequence":"additional","affiliation":[{"name":"Phebe Hospital, Phebe, Liberia"},{"name":"The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roice","family":"Fulton","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald Samuel","family":"Grant","sequence":"additional","affiliation":[{"name":"Kenema Government Hospital, Kenema, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndapewa","family":"Ithete","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie","family":"Illori","sequence":"additional","affiliation":[{"name":"Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamji","family":"Jan","sequence":"additional","affiliation":[{"name":"Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Kagia","sequence":"additional","affiliation":[{"name":"P95 Clinical and Epidemiology Services, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Martens","sequence":"additional","affiliation":[{"name":"M-script Medical Writing Services Goudenregenstraat 17, Mechelen, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Menon","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminata","family":"Ndiaye","sequence":"additional","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Ndifon","sequence":"additional","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nsaibirni","sequence":"additional","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ntiri","sequence":"additional","affiliation":[{"name":"Margan Clinical Research Organization, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Oloo","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvanus","family":"Okogbenin","sequence":"additional","affiliation":[{"name":"Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Penfold","sequence":"additional","affiliation":[{"name":"P95 Clinical and Epidemiology Services, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie","family":"Sankawulo-Ricks","sequence":"additional","affiliation":[{"name":"Phebe Hospital, Phebe, Liberia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Sillah","sequence":"additional","affiliation":[{"name":"Kenema Government Hospital, Kenema, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Suykerbuyk","sequence":"additional","affiliation":[{"name":"P95 Clinical and Epidemiology Services, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Tornieporth","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie J","family":"Vielle","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Williams","sequence":"additional","affiliation":[{"name":"Margan Clinical Research Organization, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-0212","authenticated-orcid":false,"given":"David","family":"Wohl","sequence":"additional","affiliation":[{"name":"Phebe Hospital, Phebe, Liberia"},{"name":"The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Yimer","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Gabrielle","family":"Breugelmans","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"2026010703055762000_3.2.e001960.1","unstructured":"World Health Organization . Lassa fever. Geneva, Switzerland, 2017."},{"key":"2026010703055762000_3.2.e001960.2","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2017.1369643"},{"key":"2026010703055762000_3.2.e001960.3","doi-asserted-by":"crossref","unstructured":"Wilkinson A . Beyond biosecurity: the politics of lassa fever in sierra leone in. In: Bardosh K , ed. One health: science, politics, and zoonotic disease in Africa. London (NY): Routledge, 2016: 117\u201338.","DOI":"10.4324\/9781315659749-7"},{"key":"2026010703055762000_3.2.e001960.4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.gloenvcha.2011.04.007","article-title":"The impact of future climate change on West African crop yields: What does the recent literature say?","volume":"21","author":"Roudier","year":"2011","journal-title":"Glob Environ Change"},{"key":"2026010703055762000_3.2.e001960.5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijid.2022.07.006","article-title":"Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019-2020","volume":"122","author":"Jetoh","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026010703055762000_3.2.e001960.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279467","article-title":"Epidemiological trends of Lassa fever in Nigeria, 2018-2021","volume":"17","author":"Dalhat","year":"2022","journal-title":"PLoS One"},{"key":"2026010703055762000_3.2.e001960.7","doi-asserted-by":"crossref","unstructured":"Kamara K . Analysis of National Lassa fever Surveillance Data, Sierra Leone, 2012 - 2018. Journal of Interventional Epidemiology and Public Health 2023;6. doi:10.37432\/jieph.2023.6.2.79","DOI":"10.37432\/jieph.2023.6.2.79"},{"key":"2026010703055762000_3.2.e001960.8","unstructured":"McCormick . Lassa fever update, personal communication to the world health organization. 1980."},{"key":"2026010703055762000_3.2.e001960.9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.445"},{"key":"2026010703055762000_3.2.e001960.10","unstructured":"World Health Organization . Lassa Fever, 2024. Available: https:\/\/www.who.int\/health-topics\/lassa-fever#tab=tab_1 [Accessed 19 Jan 2024]."},{"key":"2026010703055762000_3.2.e001960.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2986","article-title":"Lassa fever","volume":"358","author":"Houlihan","year":"2017","journal-title":"BMJ"},{"key":"2026010703055762000_3.2.e001960.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2026010703055762000_3.2.e001960.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450160063030"},{"key":"2026010703055762000_3.2.e001960.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00789-8"},{"key":"2026010703055762000_3.2.e001960.15","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13876"},{"key":"2026010703055762000_3.2.e001960.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010089","article-title":"A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever","volume":"16","author":"Olayinka","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2026010703055762000_3.2.e001960.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283643","article-title":"A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol","volume":"18","author":"Penfold","year":"2023","journal-title":"PLoS ONE"},{"key":"2026010703055762000_3.2.e001960.18","unstructured":"World Health Organization . Geneva, Switzerland; Lassa Fever Research and Development (R&D) Roadmap, 2019. Available: https:\/\/www.who.int\/publications\/m\/item\/lassa-fever-research-and-development-(r-d)-roadmap [Accessed 13 Mar 2024]."},{"key":"2026010703055762000_3.2.e001960.19","unstructured":"REDCap . Available: https:\/\/projectredcap.org\/software\/ [Accessed 29 Apr 2024]."},{"key":"2026010703055762000_3.2.e001960.20","unstructured":"The Brighton Collaboration . SNHL working group. definition of sensorineural hearing loss. 2019."},{"key":"2026010703055762000_3.2.e001960.21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.21-1297","article-title":"Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs","volume":"107","author":"Chughlay","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"2026010703055762000_3.2.e001960.22","doi-asserted-by":"publisher","DOI":"10.1586\/eri.13.45"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2024-001960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:06:42Z","timestamp":1767784002000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2024-001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,31]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjph-2024-001960"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2024-001960","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}